Advertisement
Advertisement

RNXT

RNXT logo

RenovoRx, Inc. Common Stock

0.98
USD
+0.01
+1.26%
Apr 30, 14:48 UTC -4
Open

RenovoRx, Inc. Common Stock Profile

About

RenovoRx Inc. is a biopharmaceutical company. It developed a therapy platform targeting difficult-to-treat tumors. RenovoRx Inc. is headquartered in Silicon Valley, California.

Info & Links

CEO

Shaun R. Bagai

Headquarters

2570 West El Camino Real, Suite 320
Mountain View, CA 94040, UNITED STATES

Sector

Medical

Auditor

Frank, Rimerman + Co. LLP

Share holders

129

Employees

10

RenovoRx, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

35.89M

Enterprise Value

28.73M

Enterprise Value/EBITDA(ttm)

-2.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.49

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-205.96%

Return on Invested Capital(ttm)

-185.88%

Return on Assets(ttm)

-110.01%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.01M

Net Income Available to Common(ttm)

-8.81M

Diluted EPS(ttm)

-0.57

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

-18.84%

S&P 500 52-Week Change

9.55%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

36.55M

Dividend Yield

0.00%

Float4

22.30M

% Held by Insiders

7.10%

% Held by Institutions

3.10%

Balance Sheet

Total Cash(mrq)

7.15M

Total Cash Per Share(mrq)

0.20

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.10%

Quick Ratio(mrq)

5.66%

Book Value Per Share(mrq)

0.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.41

Free Cash Flow(ytd)

-9.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement